Home Summit Therapeutics Reports Encouraging Clinical Data and FDA BLA Acceptance for Ivonescimab

Summit Therapeutics Reports Encouraging Clinical Data and FDA BLA Acceptance for Ivonescimab

May 31, 2026 19:50 CST Updated 20:11